Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Open-market sale 10% owner sold 2,764 shares at $8.51 ($23,522)
  2. 4 Open-market sale 10% owner sold 81,787 shares at an average $8.55 ($699,666)
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale 10% owner sold 23,660 shares at $8.56 ($202,541)
  5. 4 Open-market sale 10% owner sold 127,992 shares at an average $8.59 ($1,099,265)
  6. 4 Exercise or conversion Chief Accounting Officer acquired 339 shares (option exercise)
  7. 4 Exercise or conversion Head of Alzheimer's Disease acquired 372 shares (option exercise)
  8. 4 Open-market sale 10% owner sold 2,604 shares at an average $8.51 ($22,166)
  9. 4 Open-market sale 10% owner sold 28,884 shares at $8.60 ($248,434)
  10. 4 Exercise or conversion EVP, Chief Financial Officer acquired 6,005 shares (option exercise)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 775 shares (grant or award)
  13. 4 Grant or award Director acquired 775 shares (grant or award)
  14. 4 Grant or award Director acquired 775 shares (grant or award)
  15. 4 Grant or award Director acquired 775 shares (grant or award)
  16. 4 Grant or award Director acquired 775 shares (grant or award)
  17. 4 Grant or award Director acquired 775 shares (grant or award)
  18. 4 Grant or award Director acquired 775 shares (grant or award)
  19. 4 Grant or award Director acquired 775 shares (grant or award)
  20. 4 Grant or award Director acquired 1,275 shares (grant or award)

Page 13 of 86 · 1,714 filings